Impaired glucose tolerance Nutritional, Metabolic, Endocrine Abnormal glucose tolerance test
Conditions
Interventions
Participants will wear two FreeStyle Libre Pro Flash Glucose Monitoring Sensors for up to 14 days, followed by FreeStyle Libre for up to 14 days. During the Libre Pro sensor wear, participants will we
Sponsors
Abbott Diabetes Care Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or over. 2. Most recent HbA1c 5.7-6.4% (39-47 mmol/mol), recorded in medical notes in last 12 months.
Exclusion criteria
Exclusion criteria: 1. Recorded diagnosis of diabetes. 2. Concomitant disease or condition that may compromise patient safety including and not limited to; cystic fibrosis, severe mental illness, a diagnosed or suspected eating disorder or any uncontrolled long term medical condition. 3. Has a pacemaker or any other neurostimulators. 4. Currently receiving dialysis treatment or planning to receive dialysis during the study. 5. Women who are pregnant, plan to become pregnant or become pregnant during the study. 6. Participating in another study of a glucose monitoring device or drug that could affect glucose measurements or management. 7. Known (or suspected) allergy to medical grade adhesives. 8. In the investigator’s opinion, unsuitable to participate due to any other cause/reason.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycaemic variability (%CV glucose), measured using sensor glucose data collected by the FreeStyle Libre Pro Flash Glucose Monitoring System during the first two-weeks of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Other glycaemic measures such as time in range (3.9-10.0 mmol/L [70-180 mg/dL]), measured using sensor glucose data collected by the FreeStyle Libre Pro Flash Glucose Monitoring System during the first two-weeks of the study. | — |
Countries
England, United Kingdom
Contacts
Public ContactPamela Reid
Outcome results
None listed